Literature DB >> 7991529

Chronic hepatitis: morphology and nomenclature.

K G Ishak1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7991529

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  33 in total

1.  The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C.

Authors:  Dina Hazem Ziada; Sherif El Saadany; Mohamed Enaba; Medhat Ghazy; Azza Hasan
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Effect of interferon therapy on bile duct inflammation in hepatitis C.

Authors:  B F Banner; C Allan; L Smith; L Savas; H L Bonkovsky
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

Authors:  Robert J Fontana; Jules L Dienstag; Herbert L Bonkovsky; Richard K Sterling; Deepa Naishadham; Zachary D Goodman; Anna S F Lok; Elizabeth C Wright; Grace L Su
Journal:  Gut       Date:  2010-07-30       Impact factor: 23.059

Review 4.  Liver biopsy diagnosis of hepatitis: clues to clinically-meaningful reporting.

Authors:  Elizabeth M Brunt
Journal:  Mo Med       Date:  2010 Mar-Apr

5.  Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.

Authors:  Adrian M Di Bisceglie; Anne M Stoddard; Jules L Dienstag; Mitchell L Shiffman; Leonard B Seeff; Herbert L Bonkovsky; Chihiro Morishima; Elizabeth C Wright; Kristin K Snow; William M Lee; Robert J Fontana; Timothy R Morgan; Marc G Ghany
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

6.  Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study.

Authors:  Dinesh Jothimani; Mathew E Cramp; Tim J S Cross
Journal:  J Clin Exp Hepatol       Date:  2014-06-24

7.  Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.

Authors:  Kei Fujiwara; Yasuhito Tanaka; Emma Paulon; Etsuro Orito; Masaya Sugiyama; Kiyoaki Ito; Ryuzo Ueda; Masashi Mizokami; Nikolai V Naoumov
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 8.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

9.  YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.

Authors:  Robert J Fontana; Heather J Litman; Jules L Dienstag; Herbert L Bonkovsky; Grace Su; Richard K Sterling; Anna S Lok
Journal:  Liver Int       Date:  2011-11-22       Impact factor: 5.828

10.  Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Authors:  Adrian M Di Bisceglie; Mitchell L Shiffman; Gregory T Everson; Karen L Lindsay; James E Everhart; Elizabeth C Wright; William M Lee; Anna S Lok; Herbert L Bonkovsky; Timothy R Morgan; Marc G Ghany; Chihiro Morishima; Kristin K Snow; Jules L Dienstag
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.